Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Vicenza – page 3

92 clinical trials in Vicenza, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Vicenza at a glance
92
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

92 trials in Vicenza

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Amsacrine
  • Sponsor:Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Revumenib
  • Sponsor:Syndax Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Fondazione GONO G.I.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Fondazione IRCCS Istituto Nazionale Dei Tumori
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate
  • Sponsor:Blueprint Medicines Corp.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Ospedale San Raffaele S.r.l.
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efanesoctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Adeno-Associated Virus Vector Serotype 8 Containing The Human F9 Gene
  • Sponsor:Regeneron Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Cyclophosphamide
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Psoriasis

Not yet recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Janssen - Cilag International
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Vicenza

What the registry says about research in the country

01 Hematologic Malignancies

Groundbreaking research focusing on leukemia treatments, including studies of BCR-ABL1+ Chronic Myeloid Leukemia and innovative therapies for Acute Myeloid Leukemia. Clinical trials are evaluating targeted therapies and novel drug combinations.

  • Chronic Myeloid Leukemia (CML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Hairy Cell Leukemia

Studies are exploring the effectiveness of various therapeutic approaches including tyrosine kinase inhibitors and combination treatments.

02 Solid Tumors

Innovative research in treating various forms of cancer, with particular focus on ovarian cancer and breast cancer. Studies are investigating maintenance therapies and novel drug combinations.

  • Triple-negative Breast Cancer
  • Metastatic Colorectal Cancer
  • Non-small Cell Lung Cancer

Trials are evaluating targeted therapies and immunotherapy approaches for improved patient outcomes.

03 Autoimmune Conditions

Advanced research into immune disorders, including studies on Immune Thrombocytopenia and Thrombotic Thrombocytopenic Purpura. New therapeutic approaches are being tested to improve treatment outcomes.

  • Atopic Dermatitis
  • Primary Immune Thrombocytopenia
  • Autoimmune Blood Disorders

Clinical trials are investigating novel immunotherapies and targeted treatments for these conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.